RecruitingPhase 2NCT07656688

Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Clinical Study to Evaluate the Efficacy and Safety of HUC1-394 in Participant With Dry Eye Disease

Sponsor

Huons Co., Ltd.

Enrollment

150 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Dry Eye Disease (DED)

Summary

Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients with moderate to severe dry eye disease.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called HUC1-394 and a drug called Placebo for people with dry eye disease (ded). The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.